248.616.001 Boehringer Ingelheim Investigational Site — Minneapolis, Minnesota

248.616.001 Boehringer Ingelheim Investigational Site is a clinical research site located in Minneapolis, Minnesota, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

248.616.001 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Restless Legs Syndrome.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 248.616.001 Boehringer Ingelheim Investigational Site?

248.616.001 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 248.616.001 Boehringer Ingelheim Investigational Site conducted?

248.616.001 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Restless Legs Syndrome.

Is 248.616.001 Boehringer Ingelheim Investigational Site accredited by Crixeo Clinical Trials?

248.616.001 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 248.616.001 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.